PTEN and hepatocellular carcinoma: To explore whether PTEN mediates the oncogenic function of RP11-295G20.2, we knocked down PTEN in RP11-295G20.2-deficient cells and found that PTEN knockdown reversed the inhibitory effect of RP11-295G20.2 deficiency on HCC cell growth (Fig. 6e).